ID NEBU_HUMAN Reviewed; 6669 AA. AC P20929; F8WCL5; F8WCP0; Q15346; Q53QQ2; Q53TG8; DT 01-FEB-1991, integrated into UniProtKB/Swiss-Prot. DT 14-MAY-2014, sequence version 5. DT 27-MAR-2024, entry version 212. DE RecName: Full=Nebulin; GN Name=NEB; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND VARIANTS ASN-1027; HIS-1301; RP MET-1491; CYS-3360; THR-4401 AND VAL-6546. RX PubMed=7739042; DOI=10.1016/s0022-2836(95)80052-2; RA Labeit S., Kolmerer B.; RT "The complete primary structure of human nebulin and its correlation to RT muscle structure."; RL J. Mol. Biol. 248:308-315(1995). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., RA Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., RA Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., RA Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., RA Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., RA Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., RA Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., RA Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., RA Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., RA Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., RA Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., RA Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., RA Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., RA Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., RA Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., RA Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., RA Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 and RT 4."; RL Nature 434:724-731(2005). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 6263-6329. RX PubMed=1682316; DOI=10.1016/s0021-9258(18)54843-2; RA Jin J.P., Wang K.; RT "Cloning, expression, and protein interaction of human nebulin fragments RT composed of varying numbers of sequence modules."; RL J. Biol. Chem. 266:21215-21223(1991). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1811-1939. RX PubMed=3397062; DOI=10.1016/0888-7543(88)90009-2; RA Zeviani M., Darras B.T., Rizzuto R., Salviati G., Betto R., Bonilla E., RA Miranda A.F., Du J., Samitt C., Dickson G., Walsh F.S., Dimauro S., RA Francke U., Schon E.A.; RT "Cloning and expression of human nebulin cDNAs and assignment of the gene RT to chromosome 2q31-q32."; RL Genomics 2:249-256(1988). RN [5] RP INTERACTION WITH TTN. RX PubMed=12482578; DOI=10.1016/s0014-5793(02)03655-4; RA Ma K., Wang K.; RT "Interaction of nebulin SH3 domain with titin PEVK and myopalladin: RT implications for the signaling and assembly role of titin and nebulin."; RL FEBS Lett. 532:273-278(2002). RN [6] RP SUBUNIT, AND INTERACTION WITH DES. RX PubMed=23615443; DOI=10.1091/mbc.e12-11-0840; RA Baker L.K., Gillis D.C., Sharma S., Ambrus A., Herrmann H., Conover G.M.; RT "Nebulin binding impedes mutant desmin filament assembly."; RL Mol. Biol. Cell 24:1918-1932(2013). RN [7] RP STRUCTURE BY NMR OF 6610-6669. RX PubMed=9514727; DOI=10.1006/jmbi.1997.1521; RA Politou A.S., Millevoi S., Gautel M., Kolmerer B., Pastore A.; RT "SH3 in muscles: solution structure of the SH3 domain from nebulin."; RL J. Mol. Biol. 276:189-202(1998). RN [8] RP INVOLVEMENT IN NEM2, AND INVOLVEMENT IN AMC6. RX PubMed=10051637; DOI=10.1073/pnas.96.5.2305; RA Pelin K., Hilpelae P., Donner K., Sewry C., Akkari P.A., Wilton S.D., RA Wattanasirichaigoon D., Bang M.-L., Centner T., Hanefeld F., Odent S., RA Fardeau M., Urtizberea J.A., Muntoni F., Dubowitz V., Beggs A.H., RA Laing N.G., Labeit S., de la Chapelle A., Wallgren-Pettersson C.; RT "Mutations in the nebulin gene associated with autosomal recessive nemaline RT myopathy."; RL Proc. Natl. Acad. Sci. U.S.A. 96:2305-2310(1999). RN [9] RP INVOLVEMENT IN AMC6. RX PubMed=21798101; DOI=10.1186/2044-5040-1-23; RA Lawlor M.W., Ottenheijm C.A., Lehtokari V.L., Cho K., Pelin K., RA Wallgren-Pettersson C., Granzier H., Beggs A.H.; RT "Novel mutations in NEB cause abnormal nebulin expression and markedly RT impaired muscle force generation in severe nemaline myopathy."; RL Skelet. Muscle 1:23-23(2011). RN [10] RP INTERACTION WITH SVIL. RX PubMed=18639526; DOI=10.1016/j.bbrc.2008.07.036; RA Lee M.-A., Joo Y.M., Lee Y.M., Kim H.S., Kim J.-H., Choi J.-K., Ahn S.-J., RA Min B.-I., Kim C.-R.; RT "Archvillin anchors in the Z-line of skeletal muscle via the nebulin C- RT terminus."; RL Biochem. Biophys. Res. Commun. 374:320-324(2008). RN [11] RP VARIANT AMC6 974-ARG--ILE-6669 DEL, AND INVOLVEMENT IN AMC6. RX PubMed=26578207; DOI=10.1186/s13023-015-0364-0; RA Todd E.J., Yau K.S., Ong R., Slee J., McGillivray G., Barnett C.P., RA Haliloglu G., Talim B., Akcoren Z., Kariminejad A., Cairns A., Clarke N.F., RA Freckmann M.L., Romero N.B., Williams D., Sewry C.A., Colley A., Ryan M.M., RA Kiraly-Borri C., Sivadorai P., Allcock R.J., Beeson D., Maxwell S., RA Davis M.R., Laing N.G., Ravenscroft G.; RT "Next generation sequencing in a large cohort of patients presenting with RT neuromuscular disease before or at birth."; RL Orphanet J. Rare Dis. 10:148-148(2015). RN [12] RP VARIANTS AMC6 4561-TYR--ILE-6669 DEL AND 4626-TYR--ILE-6669 DEL, AND RP INVOLVEMENT IN AMC6. RX PubMed=29274205; DOI=10.1002/ajmg.a.38577; RA Ahmed A.A., Skaria P., Safina N.P., Thiffault I., Kats A., Taboada E., RA Habeebu S., Saunders C.; RT "Arthrogryposis and pterygia as lethal end manifestations of genetically RT defined congenital myopathies."; RL Am. J. Med. Genet. A 176:359-367(2018). CC -!- FUNCTION: This giant muscle protein may be involved in maintaining the CC structural integrity of sarcomeres and the membrane system associated CC with the myofibrils. Binds and stabilize F-actin. CC -!- SUBUNIT: Monomer and homooligomer (PubMed:23615443). Interacts with CC TTN/titin (PubMed:12482578). Interacts with SVIL (PubMed:18639526). CC Interacts (via nebulin repeats 160-164) with DES (PubMed:23615443). CC {ECO:0000269|PubMed:12482578, ECO:0000269|PubMed:18639526, CC ECO:0000269|PubMed:23615443}. CC -!- INTERACTION: CC P20929; O75923: DYSF; NbExp=6; IntAct=EBI-1049657, EBI-2799016; CC P20929; O60662: KLHL41; NbExp=8; IntAct=EBI-1049657, EBI-5353084; CC P20929; Q86TC9: MYPN; NbExp=2; IntAct=EBI-1049657, EBI-2562606; CC P20929; Q07889: SOS1; NbExp=3; IntAct=EBI-1049657, EBI-297487; CC P20929; O95425: SVIL; NbExp=4; IntAct=EBI-1049657, EBI-487145; CC P20929; Q8WZ42: TTN; NbExp=6; IntAct=EBI-1049657, EBI-681210; CC P20929-4; O60662: KLHL41; NbExp=5; IntAct=EBI-9531519, EBI-5353084; CC -!- SUBCELLULAR LOCATION: Cytoplasm, myofibril, sarcomere. Cytoplasm, CC cytoskeleton. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Name=1; CC IsoId=P20929-1; Sequence=Displayed; CC Name=2; CC IsoId=P20929-2; Sequence=VSP_054445, VSP_054446, VSP_054447, CC VSP_054448; CC Name=3; CC IsoId=P20929-3; Sequence=VSP_054445, VSP_054446, VSP_054448; CC Name=4; CC IsoId=P20929-4; Sequence=VSP_054444; CC -!- TISSUE SPECIFICITY: Muscle specific. Located in the thin filament of CC striated muscle. CC -!- DISEASE: Nemaline myopathy 2 (NEM2) [MIM:256030]: A form of nemaline CC myopathy. Nemaline myopathies are muscular disorders characterized by CC muscle weakness of varying severity and onset, and abnormal thread-like CC or rod-shaped structures in muscle fibers on histologic examination. CC {ECO:0000269|PubMed:10051637}. Note=The disease is caused by variants CC affecting the gene represented in this entry. CC -!- DISEASE: Arthrogryposis multiplex congenita 6 (AMC6) [MIM:619334]: A CC form of arthrogryposis multiplex congenita, a developmental condition CC characterized by multiple joint contractures resulting from reduced or CC absent fetal movements. AMC6 is an autosomal recessive lethal form. CC Death usually occurs in utero or in infancy. CC {ECO:0000269|PubMed:10051637, ECO:0000269|PubMed:21798101, CC ECO:0000269|PubMed:26578207, ECO:0000269|PubMed:29274205}. Note=The CC disease is caused by variants affecting the gene represented in this CC entry. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X83957; CAA58788.1; -; mRNA. DR EMBL; AC009497; AAY14651.1; -; Genomic_DNA. DR EMBL; AC107052; AAY14977.1; -; Genomic_DNA. DR EMBL; AC116650; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; M19669; AAA59917.1; -; mRNA. DR CCDS; CCDS46424.1; -. [P20929-4] DR CCDS; CCDS54407.1; -. [P20929-2] DR CCDS; CCDS54408.1; -. [P20929-3] DR PIR; A29979; A29979. DR PIR; B29979; B29979. DR PIR; S55024; S55024. DR RefSeq; NP_004534.2; NM_004543.4. [P20929-4] DR PDB; 1ARK; NMR; -; A=6610-6669. DR PDB; 1NEB; NMR; -; A=6610-6669. DR PDB; 6Y17; X-ray; 1.56 A; C/D=6610-6669. DR PDBsum; 1ARK; -. DR PDBsum; 1NEB; -. DR PDBsum; 6Y17; -. DR SMR; P20929; -. DR BioGRID; 110783; 57. DR IntAct; P20929; 36. DR MINT; P20929; -. DR STRING; 9606.ENSP00000484342; -. DR CarbonylDB; P20929; -. DR GlyGen; P20929; 3 sites, 1 O-linked glycan (3 sites). DR iPTMnet; P20929; -. DR PhosphoSitePlus; P20929; -. DR SwissPalm; P20929; -. DR BioMuta; NEB; -. DR DMDM; 313104310; -. DR EPD; P20929; -. DR jPOST; P20929; -. DR MassIVE; P20929; -. DR PeptideAtlas; P20929; -. DR ProteomicsDB; 31194; -. DR ProteomicsDB; 31219; -. DR ProteomicsDB; 53825; -. [P20929-1] DR Antibodypedia; 1171; 142 antibodies from 26 providers. DR DNASU; 4703; -. DR Ensembl; ENST00000397345.8; ENSP00000380505.3; ENSG00000183091.21. [P20929-2] DR Ensembl; ENST00000409198.5; ENSP00000386259.1; ENSG00000183091.21. [P20929-4] DR Ensembl; ENST00000427231.7; ENSP00000416578.2; ENSG00000183091.21. [P20929-3] DR GeneID; 4703; -. DR KEGG; hsa:4703; -. DR MANE-Select; ENST00000397345.8; ENSP00000380505.3; NM_001164508.2; NP_001157980.2. [P20929-2] DR UCSC; uc002txu.3; human. [P20929-1] DR AGR; HGNC:7720; -. DR CTD; 4703; -. DR DisGeNET; 4703; -. DR GeneCards; NEB; -. DR HGNC; HGNC:7720; NEB. DR HPA; ENSG00000183091; Group enriched (skeletal muscle, tongue). DR MalaCards; NEB; -. DR MIM; 161650; gene. DR MIM; 256030; phenotype. DR MIM; 619334; phenotype. DR neXtProt; NX_P20929; -. DR OpenTargets; ENSG00000183091; -. DR Orphanet; 171439; Childhood-onset nemaline myopathy. DR Orphanet; 399103; Distal nebulin myopathy. DR Orphanet; 171433; Intermediate nemaline myopathy. DR Orphanet; 33108; Lethal multiple pterygium syndrome. DR Orphanet; 171430; Severe congenital nemaline myopathy. DR Orphanet; 171436; Typical nemaline myopathy. DR PharmGKB; PA31530; -. DR VEuPathDB; HostDB:ENSG00000183091; -. DR GeneTree; ENSGT00940000154533; -. DR HOGENOM; CLU_000024_0_0_1; -. DR InParanoid; P20929; -. DR OMA; WRYREQY; -. DR OrthoDB; 3816962at2759; -. DR TreeFam; TF319104; -. DR PathwayCommons; P20929; -. DR Reactome; R-HSA-390522; Striated Muscle Contraction. DR SignaLink; P20929; -. DR SIGNOR; P20929; -. DR BioGRID-ORCS; 4703; 13 hits in 1141 CRISPR screens. DR ChiTaRS; NEB; human. DR EvolutionaryTrace; P20929; -. DR GenomeRNAi; 4703; -. DR Pharos; P20929; Tbio. DR PRO; PR:P20929; -. DR Proteomes; UP000005640; Chromosome 2. DR RNAct; P20929; Protein. DR Bgee; ENSG00000183091; Expressed in gluteal muscle and 126 other cell types or tissues. DR ExpressionAtlas; P20929; baseline and differential. DR GO; GO:0015629; C:actin cytoskeleton; TAS:ProtInc. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0030018; C:Z disc; IDA:UniProtKB. DR GO; GO:0051015; F:actin filament binding; IBA:GO_Central. DR GO; GO:0008307; F:structural constituent of muscle; TAS:ProtInc. DR GO; GO:0071691; P:cardiac muscle thin filament assembly; IBA:GO_Central. DR GO; GO:0007517; P:muscle organ development; TAS:ProtInc. DR GO; GO:0030832; P:regulation of actin filament length; NAS:UniProtKB. DR GO; GO:0007525; P:somatic muscle development; NAS:UniProtKB. DR CDD; cd11933; SH3_Nebulin_C; 1. DR Gene3D; 2.30.30.40; SH3 Domains; 1. DR InterPro; IPR013998; Nebulin-like. DR InterPro; IPR000900; Nebulin_repeat. DR InterPro; IPR035629; Nebulin_SH3. DR InterPro; IPR036028; SH3-like_dom_sf. DR InterPro; IPR001452; SH3_domain. DR PANTHER; PTHR11039; NEBULIN; 1. DR PANTHER; PTHR11039:SF37; NEBULIN; 1. DR Pfam; PF00880; Nebulin; 105. DR Pfam; PF14604; SH3_9; 1. DR PRINTS; PR00510; NEBULIN. DR SMART; SM00227; NEBU; 181. DR SMART; SM00326; SH3; 1. DR SUPFAM; SSF50044; SH3-domain; 1. DR PROSITE; PS51216; NEBULIN; 181. DR PROSITE; PS50002; SH3; 1. DR Genevisible; P20929; HS. PE 1: Evidence at protein level; KW 3D-structure; Actin-binding; Alternative splicing; Cytoplasm; Cytoskeleton; KW Disease variant; Muscle protein; Nemaline myopathy; Reference proteome; KW Repeat; SH3 domain. FT CHAIN 1..6669 FT /note="Nebulin" FT /id="PRO_0000096775" FT REPEAT 76..107 FT /note="Nebulin 1" FT REPEAT 113..143 FT /note="Nebulin 2" FT REPEAT 148..178 FT /note="Nebulin 3" FT REPEAT 183..213 FT /note="Nebulin 4" FT REPEAT 218..248 FT /note="Nebulin 5" FT REPEAT 253..283 FT /note="Nebulin 6" FT REPEAT 289..318 FT /note="Nebulin 7" FT REPEAT 324..354 FT /note="Nebulin 8" FT REPEAT 363..393 FT /note="Nebulin 9" FT REPEAT 398..428 FT /note="Nebulin 10" FT REPEAT 434..464 FT /note="Nebulin 11" FT REPEAT 502..532 FT /note="Nebulin 12" FT REPEAT 537..567 FT /note="Nebulin 13" FT REPEAT 573..603 FT /note="Nebulin 14" FT REPEAT 611..641 FT /note="Nebulin 15" FT REPEAT 681..711 FT /note="Nebulin 16" FT REPEAT 749..779 FT /note="Nebulin 17" FT REPEAT 784..814 FT /note="Nebulin 18" FT REPEAT 820..850 FT /note="Nebulin 19" FT REPEAT 858..888 FT /note="Nebulin 20" FT REPEAT 893..923 FT /note="Nebulin 21" FT REPEAT 924..954 FT /note="Nebulin 22" FT REPEAT 959..990 FT /note="Nebulin 23" FT REPEAT 993..1023 FT /note="Nebulin 24" FT REPEAT 1028..1058 FT /note="Nebulin 25" FT REPEAT 1064..1094 FT /note="Nebulin 26" FT REPEAT 1102..1132 FT /note="Nebulin 27" FT REPEAT 1137..1167 FT /note="Nebulin 28" FT REPEAT 1168..1198 FT /note="Nebulin 29" FT REPEAT 1204..1234 FT /note="Nebulin 30" FT REPEAT 1237..1267 FT /note="Nebulin 31" FT REPEAT 1272..1302 FT /note="Nebulin 32" FT REPEAT 1308..1338 FT /note="Nebulin 33" FT REPEAT 1346..1376 FT /note="Nebulin 34" FT REPEAT 1381..1411 FT /note="Nebulin 35" FT REPEAT 1412..1442 FT /note="Nebulin 36" FT REPEAT 1448..1478 FT /note="Nebulin 37" FT REPEAT 1481..1511 FT /note="Nebulin 38" FT REPEAT 1516..1546 FT /note="Nebulin 39" FT REPEAT 1552..1582 FT /note="Nebulin 40" FT REPEAT 1590..1620 FT /note="Nebulin 41" FT REPEAT 1625..1655 FT /note="Nebulin 42" FT REPEAT 1656..1686 FT /note="Nebulin 43" FT REPEAT 1692..1722 FT /note="Nebulin 44" FT REPEAT 1725..1755 FT /note="Nebulin 45" FT REPEAT 1760..1790 FT /note="Nebulin 46" FT REPEAT 1796..1826 FT /note="Nebulin 47" FT REPEAT 1834..1864 FT /note="Nebulin 48" FT REPEAT 1869..1899 FT /note="Nebulin 49" FT REPEAT 1900..1930 FT /note="Nebulin 50" FT REPEAT 1936..1966 FT /note="Nebulin 51" FT REPEAT 1969..1999 FT /note="Nebulin 52" FT REPEAT 2004..2034 FT /note="Nebulin 53" FT REPEAT 2040..2070 FT /note="Nebulin 54" FT REPEAT 2078..2108 FT /note="Nebulin 55" FT REPEAT 2113..2143 FT /note="Nebulin 56" FT REPEAT 2144..2174 FT /note="Nebulin 57" FT REPEAT 2180..2210 FT /note="Nebulin 58" FT REPEAT 2213..2243 FT /note="Nebulin 59" FT REPEAT 2248..2278 FT /note="Nebulin 60" FT REPEAT 2284..2314 FT /note="Nebulin 61" FT REPEAT 2322..2352 FT /note="Nebulin 62" FT REPEAT 2357..2387 FT /note="Nebulin 63" FT REPEAT 2388..2418 FT /note="Nebulin 64" FT REPEAT 2423..2453 FT /note="Nebulin 65" FT REPEAT 2456..2486 FT /note="Nebulin 66" FT REPEAT 2491..2521 FT /note="Nebulin 67" FT REPEAT 2527..2557 FT /note="Nebulin 68" FT REPEAT 2565..2595 FT /note="Nebulin 69" FT REPEAT 2600..2630 FT /note="Nebulin 70" FT REPEAT 2631..2661 FT /note="Nebulin 71" FT REPEAT 2666..2696 FT /note="Nebulin 72" FT REPEAT 2699..2729 FT /note="Nebulin 73" FT REPEAT 2734..2764 FT /note="Nebulin 74" FT REPEAT 2770..2800 FT /note="Nebulin 75" FT REPEAT 2808..2838 FT /note="Nebulin 76" FT REPEAT 2843..2873 FT /note="Nebulin 77" FT REPEAT 2874..2904 FT /note="Nebulin 78" FT REPEAT 2909..2939 FT /note="Nebulin 79" FT REPEAT 2942..2972 FT /note="Nebulin 80" FT REPEAT 2977..3007 FT /note="Nebulin 81" FT REPEAT 3013..3043 FT /note="Nebulin 82" FT REPEAT 3051..3081 FT /note="Nebulin 83" FT REPEAT 3086..3116 FT /note="Nebulin 84" FT REPEAT 3117..3147 FT /note="Nebulin 85" FT REPEAT 3152..3182 FT /note="Nebulin 86" FT REPEAT 3185..3215 FT /note="Nebulin 87" FT REPEAT 3220..3250 FT /note="Nebulin 88" FT REPEAT 3256..3286 FT /note="Nebulin 89" FT REPEAT 3294..3324 FT /note="Nebulin 90" FT REPEAT 3329..3359 FT /note="Nebulin 91" FT REPEAT 3360..3390 FT /note="Nebulin 92" FT REPEAT 3395..3425 FT /note="Nebulin 93" FT REPEAT 3428..3458 FT /note="Nebulin 94" FT REPEAT 3463..3493 FT /note="Nebulin 95" FT REPEAT 3499..3529 FT /note="Nebulin 96" FT REPEAT 3537..3567 FT /note="Nebulin 97" FT REPEAT 3572..3602 FT /note="Nebulin 98" FT REPEAT 3603..3633 FT /note="Nebulin 99" FT REPEAT 3638..3668 FT /note="Nebulin 100" FT REPEAT 3671..3701 FT /note="Nebulin 101" FT REPEAT 3706..3736 FT /note="Nebulin 102" FT REPEAT 3742..3772 FT /note="Nebulin 103" FT REPEAT 3780..3810 FT /note="Nebulin 104" FT REPEAT 3815..3845 FT /note="Nebulin 105" FT REPEAT 3846..3876 FT /note="Nebulin 106" FT REPEAT 3914..3944 FT /note="Nebulin 107" FT REPEAT 3949..3979 FT /note="Nebulin 108" FT REPEAT 3984..4014 FT /note="Nebulin 109" FT REPEAT 4021..4052 FT /note="Nebulin 110" FT REPEAT 4057..4087 FT /note="Nebulin 111" FT REPEAT 4088..4118 FT /note="Nebulin 112" FT REPEAT 4123..4153 FT /note="Nebulin 113" FT REPEAT 4156..4186 FT /note="Nebulin 114" FT REPEAT 4191..4220 FT /note="Nebulin 115" FT REPEAT 4226..4256 FT /note="Nebulin 116" FT REPEAT 4264..4294 FT /note="Nebulin 117" FT REPEAT 4299..4329 FT /note="Nebulin 118" FT REPEAT 4330..4360 FT /note="Nebulin 119" FT REPEAT 4365..4395 FT /note="Nebulin 120" FT REPEAT 4400..4430 FT /note="Nebulin 121" FT REPEAT 4435..4465 FT /note="Nebulin 122" FT REPEAT 4471..4501 FT /note="Nebulin 123" FT REPEAT 4544..4574 FT /note="Nebulin 124" FT REPEAT 4575..4605 FT /note="Nebulin 125" FT REPEAT 4610..4640 FT /note="Nebulin 126" FT REPEAT 4645..4675 FT /note="Nebulin 127" FT REPEAT 4680..4710 FT /note="Nebulin 128" FT REPEAT 4716..4746 FT /note="Nebulin 129" FT REPEAT 4754..4784 FT /note="Nebulin 130" FT REPEAT 4789..4819 FT /note="Nebulin 131" FT REPEAT 4820..4850 FT /note="Nebulin 132" FT REPEAT 4855..4885 FT /note="Nebulin 133" FT REPEAT 4890..4920 FT /note="Nebulin 134" FT REPEAT 4926..4956 FT /note="Nebulin 135" FT REPEAT 4961..4991 FT /note="Nebulin 136" FT REPEAT 4997..5027 FT /note="Nebulin 137" FT REPEAT 5032..5062 FT /note="Nebulin 138" FT REPEAT 5067..5097 FT /note="Nebulin 139" FT REPEAT 5137..5167 FT /note="Nebulin 140" FT REPEAT 5172..5202 FT /note="Nebulin 141" FT REPEAT 5207..5237 FT /note="Nebulin 142" FT REPEAT 5242..5272 FT /note="Nebulin 143" FT REPEAT 5277..5307 FT /note="Nebulin 144" FT REPEAT 5312..5342 FT /note="Nebulin 145" FT REPEAT 5347..5377 FT /note="Nebulin 146" FT REPEAT 5382..5412 FT /note="Nebulin 147" FT REPEAT 5417..5447 FT /note="Nebulin 148" FT REPEAT 5452..5482 FT /note="Nebulin 149" FT REPEAT 5488..5518 FT /note="Nebulin 150" FT REPEAT 5523..5553 FT /note="Nebulin 151" FT REPEAT 5558..5588 FT /note="Nebulin 152" FT REPEAT 5593..5623 FT /note="Nebulin 153" FT REPEAT 5628..5658 FT /note="Nebulin 154" FT REPEAT 5665..5695 FT /note="Nebulin 155" FT REPEAT 5702..5732 FT /note="Nebulin 156" FT REPEAT 5736..5766 FT /note="Nebulin 157" FT REPEAT 5771..5801 FT /note="Nebulin 158" FT REPEAT 5808..5838 FT /note="Nebulin 159" FT REPEAT 5843..5873 FT /note="Nebulin 160" FT REPEAT 5878..5908 FT /note="Nebulin 161" FT REPEAT 5911..5943 FT /note="Nebulin 162" FT REPEAT 5950..5980 FT /note="Nebulin 163" FT REPEAT 5987..6017 FT /note="Nebulin 164" FT REPEAT 6025..6055 FT /note="Nebulin 165" FT REPEAT 6060..6090 FT /note="Nebulin 166" FT REPEAT 6095..6125 FT /note="Nebulin 167" FT REPEAT 6130..6160 FT /note="Nebulin 168" FT REPEAT 6161..6191 FT /note="Nebulin 169" FT REPEAT 6192..6222 FT /note="Nebulin 170" FT REPEAT 6223..6253 FT /note="Nebulin 171" FT REPEAT 6255..6284 FT /note="Nebulin 172" FT REPEAT 6285..6315 FT /note="Nebulin 173" FT REPEAT 6316..6346 FT /note="Nebulin 174" FT REPEAT 6347..6377 FT /note="Nebulin 175" FT REPEAT 6378..6408 FT /note="Nebulin 176" FT REPEAT 6414..6444 FT /note="Nebulin 177" FT REPEAT 6449..6479 FT /note="Nebulin 178" FT DOMAIN 6610..6669 FT /note="SH3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00192" FT REGION 34..73 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 6457..6612 FT /note="Interaction with SVIL" FT /evidence="ECO:0000269|PubMed:18639526" FT REGION 6529..6566 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 6583..6607 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 34..52 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 6529..6549 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT VAR_SEQ 2959..2960 FT /note="IT -> LN (in isoform 4)" FT /evidence="ECO:0000303|PubMed:7739042" FT /id="VSP_054444" FT VAR_SEQ 2973 FT /note="D -> DKTQIHIMPDTPEIMLARMNKINYSESLYKLANEEAKKKGYDLRSDA FT IPIVAAKASRDIISDYKYKDGYCKQLGHHIGARNIEDDPKMMWSMHVAKIQSDREYKKD FT FEKWKTKFSSPVDMLGVVLAKKCQTLVSDVDYKNYLHEWTCLPDQSDVIHARQAYDLQS FT DNIYKSDLQWLRGIGWVPIGSMDVVKCKRATEILSDNIYRQPPDKLKFTSVTDSLEQVL FT AKNNALNMNKRLYTEAWDKD (in isoform 2 and isoform 3)" FT /evidence="ECO:0000305" FT /id="VSP_054445" FT VAR_SEQ 3854..3859 FT /note="DIIQAK -> DIIQAKKAYDLQSDSVYKADLEWLRGIGWMPEGSVEMNRVKV FT AQDLVNERLYRTRPEALSFTSIVDTPEVVLAKANSLQISEKLYQEAWNKDKSNITIPSD FT TPEMLQAHINALQISNKLYQKDWNDAKQKGYDIRADAIEIKHAKASREIASEYKYKEGY FT RKQLGHHMGFRTLQDDPKSVWAIHAAKIQSDREYKKAYEKSKGIHNTPLDMMSIVQAKK FT CQVLVSDIDYRNYLHQWTCLPDQNDVIQAKKAYDLQSDNLYKSDLEWLKGIGWLPEGSV FT EVMRVKNAQNLLNERLYRIKPEALKFTSIVDTPEVIQAKINAVQISEPLYRDAWEKEKA FT NVNVPADTPLMLQSKINALQISNKRYQQAWEDVKMTGYDLRADAIGIQHAKASRDIASD FT YLYKTAYEKQKGHYIGCRSAKEDPKLVWAANVLKMQNDRLYKKAYNDHKAKISIPVDMV FT SISAAKEGQALASDVDYRHYLHHWSCFPDQNDVIQARKAYDLQSDSVYKADLEWLRGIG FT WMPEGSVEMNRVKVAQDLVNERLYRTRPEALSFTSIVDTPEVVLAKANSLQISEKLYQE FT AWNKDKSNITIPSDTPEMLQAHINALQISNKLYQKDWNDTKQKGYDIRADAIEIKHAKA FT SREIASEYKYKEGYRKQLGHHMGFRTLQDDPKSVWAIHAAKIQSDREYKKAYEKSKGIH FT NTPLDMMSIVQAKKCQVLVSDIDYRNYLHQWTCLPDQNDVIQAKKAYDLQSDNLYKSDL FT EWLKGIGWLPEGSVEVMRVKNAQNLLNERLYRIKPEALKFTSIVDTPEVIQAKINAVQI FT SEPLYRNAWEKEKANVNVPADTPLMLQSKINALQISNKRYQQAWEDVKMTGYDLRADAI FT GIQHAKASRDIASDYLYKTAYEKQKGHYIGCRSAKEDPKLVWAANVLKMQNDRLYKKAY FT NDHKAKISIPVDMVSISAAKEGQALASDVDYRHYLHHWSCFPDQNDVIQARKAYDLQSD FT SVYKADLEWLRGIGWMPEGSVEMNRVKVAQDLVNERLYRTRPEALSFTSIVDTPEVVLA FT KANSLQISEKLYQEAWNKDKSNITIPSDTPEMLQAHINALQISNKLYQKDWNDTKQKGY FT DIRADAIEIKHAKASREIASEYKYKEGYRKQLGHHMGFRTLQDDPKSVWAIHAAKIQSD FT REYKKAYEKSKGIHNTPLDMMSIVQAKKCQVLVSDIDYRNYLHQWTCLPDQNDVIQAKK FT AYDLQSDNLYKSDLEWLKGIGWLPEGSVEVMRVKNAQNLLNERLYRIKPEALKFTSIVD FT TPEVIQAKINAVQISEPLYRDAWEKEKANVNVPADTPLMLQSKINALQISNKRYQQAWE FT DVKMTGYDLRADAIGIQHAKASRDIASDYLYKTAYEKQKGHYIGCRSAKEDPKLVWAAN FT VLKMQNDRLYKKAYNDHKAKISIPVDMVSISAAKEGQALASDVDYRHYLHRWSCFPDQN FT DVIQAR (in isoform 2 and isoform 3)" FT /evidence="ECO:0000305" FT /id="VSP_054446" FT VAR_SEQ 5404..5436 FT /note="KKYRADYEQRKDKYHLVVDEPRHLLAKTAGDQI -> RKYKSSAKMFLQHGC FT NEILRPDMLTALYNSHMW (in isoform 2)" FT /evidence="ECO:0000305" FT /id="VSP_054447" FT VAR_SEQ 6272..6273 FT /note="NF -> NFSSILYKENLSKGTPLPVTPEMERVKLNQENFSSVLYKENVGKGI FT PIPITPEMERVKHNQENFSSVLYKENLGTGIPIPITPEMQRVKHNQENLSSVLYKENMG FT KGTPLPVTPEMERVKHNQENISSVLYKENMGKGTPLPVTPEMERVKHNQENI (in FT isoform 2 and isoform 3)" FT /evidence="ECO:0000305" FT /id="VSP_054448" FT VARIANT 146 FT /note="T -> A (in dbSNP:rs4077109)" FT /id="VAR_047692" FT VARIANT 191 FT /note="E -> Q (in dbSNP:rs35686968)" FT /id="VAR_047693" FT VARIANT 974..6669 FT /note="Missing (in AMC6)" FT /evidence="ECO:0000269|PubMed:26578207" FT /id="VAR_085714" FT VARIANT 1027 FT /note="K -> N (in dbSNP:rs6735208)" FT /evidence="ECO:0000269|PubMed:7739042" FT /id="VAR_047694" FT VARIANT 1301 FT /note="Y -> H (in dbSNP:rs6711382)" FT /evidence="ECO:0000269|PubMed:7739042" FT /id="VAR_047695" FT VARIANT 1469 FT /note="E -> D (in dbSNP:rs34800215)" FT /id="VAR_047696" FT VARIANT 1479 FT /note="V -> I (in dbSNP:rs34577613)" FT /id="VAR_047697" FT VARIANT 1491 FT /note="V -> M (in dbSNP:rs7426114)" FT /evidence="ECO:0000269|PubMed:7739042" FT /id="VAR_047698" FT VARIANT 1969 FT /note="Y -> H (in dbSNP:rs34532796)" FT /id="VAR_047699" FT VARIANT 2613 FT /note="K -> N (in dbSNP:rs13013209)" FT /id="VAR_047700" FT VARIANT 2773 FT /note="R -> Q (in dbSNP:rs35974308)" FT /id="VAR_047701" FT VARIANT 2912 FT /note="S -> P (in dbSNP:rs6713162)" FT /id="VAR_047702" FT VARIANT 2952 FT /note="V -> G (in dbSNP:rs13024542)" FT /id="VAR_047703" FT VARIANT 3360 FT /note="W -> C (in dbSNP:rs10172023)" FT /evidence="ECO:0000269|PubMed:7739042" FT /id="VAR_047704" FT VARIANT 3887 FT /note="S -> T (in dbSNP:rs35227368)" FT /id="VAR_047705" FT VARIANT 4271 FT /note="P -> L (in dbSNP:rs4327235)" FT /id="VAR_047706" FT VARIANT 4337 FT /note="N -> S (in dbSNP:rs16830236)" FT /id="VAR_047707" FT VARIANT 4401 FT /note="R -> T (in dbSNP:rs2288210)" FT /evidence="ECO:0000269|PubMed:7739042" FT /id="VAR_047708" FT VARIANT 4561..6669 FT /note="Missing (in AMC6)" FT /evidence="ECO:0000269|PubMed:29274205" FT /id="VAR_085715" FT VARIANT 4626..6669 FT /note="Missing (in AMC6)" FT /evidence="ECO:0000269|PubMed:29274205" FT /id="VAR_085716" FT VARIANT 5030 FT /note="D -> V (in dbSNP:rs2288200)" FT /id="VAR_024240" FT VARIANT 5463 FT /note="R -> P (in dbSNP:rs16830171)" FT /id="VAR_047709" FT VARIANT 5934 FT /note="G -> E (in dbSNP:rs3732309)" FT /id="VAR_021888" FT VARIANT 6131 FT /note="T -> I (in dbSNP:rs34368668)" FT /id="VAR_056953" FT VARIANT 6546 FT /note="I -> V (in dbSNP:rs1061305)" FT /evidence="ECO:0000269|PubMed:7739042" FT /id="VAR_056954" FT CONFLICT 727 FT /note="E -> D (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 781 FT /note="K -> R (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 1290 FT /note="N -> S (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 1305 FT /note="A -> R (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 1389 FT /note="S -> T (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 1549 FT /note="A -> R (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 1939 FT /note="P -> L (in Ref. 4; AAA59917)" FT /evidence="ECO:0000305" FT CONFLICT 2023 FT /note="M -> I (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 2613 FT /note="K -> Y (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 3796 FT /note="G -> E (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 3838 FT /note="D -> Y (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 5038 FT /note="T -> P (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 5132 FT /note="K -> E (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 5432..5433 FT /note="AG -> RS (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT CONFLICT 6289 FT /note="A -> P (in Ref. 1; CAA58788)" FT /evidence="ECO:0000305" FT STRAND 6615..6619 FT /evidence="ECO:0007829|PDB:6Y17" FT STRAND 6624..6628 FT /evidence="ECO:0007829|PDB:1ARK" FT STRAND 6636..6652 FT /evidence="ECO:0007829|PDB:6Y17" FT TURN 6653..6655 FT /evidence="ECO:0007829|PDB:6Y17" FT STRAND 6658..6662 FT /evidence="ECO:0007829|PDB:6Y17" FT HELIX 6663..6665 FT /evidence="ECO:0007829|PDB:6Y17" FT STRAND 6666..6668 FT /evidence="ECO:0007829|PDB:6Y17" SQ SEQUENCE 6669 AA; 772914 MW; AD93D9B6FB3D8161 CRC64; MADDEDYEEV VEYYTEEVVY EEVPGETITK IYETTTTRTS DYEQSETSKP ALAQPALAQP ASAKPVERRK VIRKKVDPSK FMTPYIAHSQ KMQDLFSPNK YKEKFEKTKG QPYASTTDTP ELRRIKKVQD QLSEVKYRMD GDVAKTICHV DEKAKDIEHA KKVSQQVSKV LYKQNWEDTK DKYLLPPDAP ELVQAVKNTA MFSKKLYTED WEADKSLFYP YNDSPELRRV AQAQKALSDV AYKKGLAEQQ AQFTPLADPP DIEFAKKVTN QVSKQKYKED YENKIKGKWS ETPCFEVANA RMNADNISTR KYQEDFENMK DQIYFMQTET PEYKMNKKAG VAASKVKYKE DYEKNKGKAD YNVLPASENP QLRQLKAAGD ALSDKLYKEN YEKTKAKSIN YCETPKFKLD TVLQNFSSDK KYKDSYLKDI LGHYVGSFED PYHSHCMKVT AQNSDKNYKA EYEEDRGKGF FPQTITQEYE AIKKLDQCKD HTYKVHPDKT KFTQVTDSPV LLQAQVNSKQ LSDLNYKAKH ESEKFKCHIP PDTPAFIQHK VNAYNLSDNL YKQDWEKSKA KKFDIKVDAI PLLAAKANTK NTSDVMYKKD YEKNKGKMIG VLSINDDPKM LHSLKVAKNQ SDRLYKENYE KTKAKSMNYC ETPKYQLDTQ LKNFSEARYK DLYVKDVLGH YVGSMEDPYH THCMKVAAQN SDKSYKAEYE EDKGKCYFPQ TITQEYEAIK KLDQCKDHTY KVHPDKTKFT AVTDSPVLLQ AQLNTKQLSD LNYKAKHEGE KFKCHIPADA PQFIQHRVNA YNLSDNVYKQ DWEKSKAKKF DIKVDAIPLL AAKANTKNTS DVMYKKDYEK SKGKMIGALS INDDPKMLHS LKTAKNQSDR EYRKDYEKSK TIYTAPLDML QVTQAKKSQA IASDVDYKHI LHSYSYPPDS INVDLAKKAY ALQSDVEYKA DYNSWMKGCG WVPFGSLEME KAKRASDILN EKKYRQHPDT LKFTSIEDAP ITVQSKINQA QRSDIAYKAK GEEIIHKYNL PPDLPQFIQA KVNAYNISEN MYKADLKDLS KKGYDLRTDA IPIRAAKAAR QAASDVQYKK DYEKAKGKMV GFQSLQDDPK LVHYMNVAKI QSDREYKKDY EKTKSKYNTP HDMFNVVAAK KAQDVVSNVN YKHSLHHYTY LPDAMDLELS KNMMQIQSDN VYKEDYNNWM KGIGWIPIGS LDVEKVKKAG DALNEKKYRQ HPDTLKFTSI VDSPVMVQAK QNTKQVSDIL YKAKGEDVKH KYTMSPDLPQ FLQAKCNAYN ISDVCYKRDW YDLIAKGNNV LGDAIPITAA KASRNIASDY KYKEAYEKSK GKHVGFRSLQ DDPKLVHYMN VAKLQSDREY KKNYENTKTS YHTPGDMVSI TAAKMAQDVA TNVNYKQPLH HYTYLPDAMS LEHTRNVNQI QSDNVYKDEY NSFLKGIGWI PIGSLEVEKV KKAGDALNER KYRQHPDTVK FTSVPDSMGM VLAQHNTKQL SDLNYKVEGE KLKHKYTIDP ELPQFIQAKV NALNMSDAHY KADWKKTIAK GYDLRPDAIP IVAAKSSRNI ASDCKYKEAY EKAKGKQVGF LSLQDDPKLV HYMNVAKIQS DREYKKGYEA SKTKYHTPLD MVSVTAAKKS QEVATNANYR QSYHHYTLLP DALNVEHSRN AMQIQSDNLY KSDFTNWMKG IGWVPIESLE VEKAKKAGEI LSEKKYRQHP EKLKFTYAMD TMEQALNKSN KLNMDKRLYT EKWNKDKTTI HVMPDTPDIL LSRVNQITMS DKLYKAGWEE EKKKGYDLRP DAIAIKAARA SRDIASDYKY KKAYEQAKGK HIGFRSLEDD PKLVHFMQVA KMQSDREYKK GYEKSKTSFH TPVDMLSVVA AKKSQEVATN ANYRNVIHTY NMLPDAMSFE LAKNMMQIQS DNQYKADYAD FMKGIGWLPL GSLEAEKNKK AMEIISEKKY RQHPDTLKYS TLMDSMNMVL AQNNAKIMNE HLYKQAWEAD KTKVHIMPDI PQIILAKANA INMSDKLYKL SLEESKKKGY DLRPDAIPIK AAKASRDIAS DYKYKYNYEK GKGKMVGFRS LEDDPKLVHS MQVAKMQSDR EYKKNYENTK TSYHTPADML SVTAAKDAQA NITNTNYKHL IHKYILLPDA MNIELTRNMN RIQSDNEYKQ DYNEWYKGLG WSPAGSLEVE KAKKATEYAS DQKYRQHPSN FQFKKLTDSM DMVLAKQNAH TMNKHLYTID WNKDKTKIHV MPDTPDILQA KQNQTLYSQK LYKLGWEEAL KKGYDLPVDA ISVQLAKASR DIASDYKYKQ GYRKQLGHHV GFRSLQDDPK LVLSMNVAKM QSEREYKKDF EKWKTKFSSP VDMLGVVLAK KCQELVSDVD YKNYLHQWTC LPDQNDVVQA KKVYELQSEN LYKSDLEWLR GIGWSPLGSL EAEKNKRASE IISEKKYRQP PDRNKFTSIP DAMDIVLAKT NAKNRSDRLY REAWDKDKTQ IHIMPDTPDI VLAKANLINT SDKLYRMGYE ELKRKGYDLP VDAIPIKAAK ASREIASEYK YKEGFRKQLG HHIGARNIED DPKMMWSMHV AKIQSDREYK KDFEKWKTKF SSPVDMLGVV LAKKCQTLVS DVDYKNYLHQ WTCLPDQSDV IHARQAYDLQ SDNLYKSDLQ WLKGIGWMTS GSLEDEKNKR ATQILSDHVY RQHPDQFKFS SLMDSIPMVL AKNNAITMNH RLYTEAWDKD KTTVHIMPDT PEVLLAKQNK VNYSEKLYKL GLEEAKRKGY DMRVDAIPIK AAKASRDIAS EFKYKEGYRK QLGHHIGARA IRDDPKMMWS MHVAKIQSDR EYKKDFEKWK TKFSSPVDML GVVLAKKCQT LVSDVDYKNY LHQWTCLPDQ SDVIHARQAY DLQSDNMYKS DLQWMRGIGW VSIGSLDVEK CKRATEILSD KIYRQPPDRF KFTSVTDSLE QVLAKNNAIT MNKRLYTEAW DKDKTQIHIM PDTPEIMLAR QNKINYSETL YKLANEEAKK KGYDLRSDAI PIVAAKASRD VISDYKYKDG YRKQLGHHIG ARNIEDDPKM MWSMHVAKIQ SDREYKKDFE KWKTKFSSPV DMLGVVLAKK CQTLVSDVDY KNYLHEWTCL PDQNDVIHAR QAYDLQSDNI YKSDLQWLRG IGWVPIGSMD VVKCKRAAEI LSDNIYRQPP DKLKFTSVTD SLEQVLAKNN ALNMNKRLYT EAWDKDKTQV HIMPDTPEIM LARQNKINYS ESLYRQAMEE AKKEGYDLRS DAIPIVAAKA SRDIASDYKY KEAYRKQLGH HIGARAVHDD PKIMWSLHIA KVQSDREYKK DFEKYKTRYS SPVDMLGIVL AKKCQTLVSD VDYKHPLHEW ICLPDQNDII HARKAYDLQS DNLYKSDLEW MKGIGWVPID SLEVVRAKRA GELLSDTIYR QRPETLKFTS ITDTPEQVLA KNNALNMNKR LYTEAWDNDK KTIHVMPDTP EIMLAKLNRI NYSDKLYKLA LEESKKEGYD LRLDAIPIQA AKASRDIASD YKYKEGYRKQ LGHHIGARNI KDDPKMMWSI HVAKIQSDRE YKKEFEKWKT KFSSPVDMLG VVLAKKCQIL VSDIDYKHPL HEWTCLPDQN DVIQARKAYD LQSDAIYKSD LEWLRGIGWV PIGSVEVEKV KRAGEILSDR KYRQPADQLK FTCITDTPEI VLAKNNALTM SKHLYTEAWD ADKTSIHVMP DTPDILLAKS NSANISQKLY TKGWDESKMK DYDLRADAIS IKSAKASRDI ASDYKYKEAY EKQKGHHIGA QSIEDDPKIM CAIHAGKIQS EREYKKEFQK WKTKFSSPVD MLSILLAKKC QTLVTDIDYR NYLHEWTCMP DQNDIIQAKK AYDLQSDALY KADLEWLRGI GWMPQGSPEV LRVKNAQNIF CDSVYRTPVV NLKYTSIVDT PEVVLAKSNA ENISIPKYRE VWDKDKTSIH IMPDTPEINL ARANALNVSN KLYREGWDEM KAGCDVRLDA IPIQAAKASR EIASDYKYKL DHEKQKGHYV GTLTARDDNK IRWALIADKL QNEREYRLDW AKWKAKIQSP VDMLSILHSK NSQALVSDMD YRNYLHQWTC MPDQNDVIQA KKAYELQSDN VYKADLEWLR GIGWMPNDSV SVNHAKHAAD IFSEKKYRTK IETLNFTPVD DRVDYVTAKQ SGEILDDIKY RKDWNATKSK YTLTETPLLH TAQEAARILD QYLYKEGWER QKATGYILPP DAVPFVHAHH CNDVQSELKY KAEHVKQKGH YVGVPTMRDD PKLVWFEHAG QIQNERLYKE DYHKTKAKIN IPADMVSVLA AKQGQTLVSD IDYRNYLHQW MCHPDQNDVI QARKAYDLQS DNVYRADLEW LRGIGWIPLD SVDHVRVTKN QEMMSQIKYK KNALENYPNF RSVVDPPEIV LAKINSVNQS DVKYKETFNK AKGKYTFSPD TPHISHSKDM GKLYSTILYK GAWEGTKAYG YTLDERYIPI VGAKHADLVN SELKYKETYE KQKGHYLAGK VIGEFPGVVH CLDFQKMRSA LNYRKHYEDT KANVHIPNDM MNHVLAKRCQ YILSDLEYRH YFHQWTSLLE EPNVIRVRNA QEILSDNVYK DDLNWLKGIG CYVWDTPQIL HAKKSYDLQS QLQYTAAGKE NLQNYNLVTD TPLYVTAVQS GINASEVKYK ENYHQIKDKY TTVLETVDYD RTRNLKNLYS SNLYKEAWDR VKATSYILPS STLSLTHAKN QKHLASHIKY REEYEKFKAL YTLPRSVDDD PNTARCLRVG KLNIDRLYRS VYEKNKMKIH IVPDMVEMVT AKDSQKKVSE IDYRLRLHEW ICHPDLQVND HVRKVTDQIS DIVYKDDLNW LKGIGCYVWD TPEILHAKHA YDLRDDIKYK AHMLKTRNDY KLVTDTPVYV QAVKSGKQLS DAVYHYDYVH SVRGKVAPTT KTVDLDRALH AYKLQSSNLY KTSLRTLPTG YRLPGDTPHF KHIKDTRYMS SYFKYKEAYE HTKAYGYTLG PKDVPFVHVR RVNNVTSERL YRELYHKLKD KIHTTPDTPE IRQVKKTQEA VSELIYKSDF FKMQGHMISL PYTPQVIHCR YVGDITSDIK YKEDLQVLKG FGCFLYDTPD MVRSRHLRKL WSNYLYTDKA RKMRDKYKVV LDTPEYRKVQ ELKTHLSELV YRAAGKKQKS IFTSVPDTPD LLRAKRGQKL QSQYLYVELA TKERPHHHAG NQTTALKHAK DVKDMVSEKK YKIQYEKMKD KYTPVPDTPI LIRAKRAYWN ASDLRYKETF QKTKGKYHTV KDALDIVYHR KVTDDISKIK YKENYMSQLG IWRSIPDRPE HFHHRAVTDT VSDVKYKEDL TWLKGIGCYA YDTPDFTLAE KNKTLYSKYK YKEVFERTKS DFKYVADSPI NRHFKYATQL MNEKKYRADY EQRKDKYHLV VDEPRHLLAK TAGDQISQIK YRKNYEKSKD KFTSIVDTPE HLRTTKVNKQ ISDILYKLEY NKAKPRGYTT IHDTPMLLHV RKVKDEVSDL KYKEVYQRNK SNCTIEPDAV HIKAAKDAYK VNTNLDYKKQ YEANKAHWKW TPDRPDFLQA AKSSLQQSDF EYKLDREFLK GCKLSVTDDK NTVLALRNTL IESDLKYKEK HVKERGTCHA VPDTPQILLA KTVSNLVSEN KYKDHVKKHL AQGSYTTLPE TRDTVHVKEV TKHVSDTNYK KKFVKEKGKS NYSIMLEPPE VKHAMEVAKK QSDVAYRKDA KENLHYTTVA DRPDIKKATQ AAKQASEVEY RAKHRKEGSH GLSMLGRPDI EMAKKAAKLS SQVKYRENFD KEKGKTPKYN PKDSQLYKVM KDANNLASEV KYKADLKKLH KPVTDMKESL IMNHVLNTSQ LASSYQYKKK YEKSKGHYHT IPDNLEQLHL KEATELQSIV KYKEKYEKER GKPMLDFETP TYITAKESQQ MQSGKEYRKD YEESIKGRNL TGLEVTPALL HVKYATKIAS EKEYRKDLEE SIRGKGLTEM EDTPDMLRAK NATQILNEKE YKRDLELEVK GRGLNAMANE TPDFMRARNA TDIASQIKYK QSAEMEKANF TSVVDTPEII HAQQVKNLSS QKKYKEDAEK SMSYYETVLD TPEIQRVREN QKNFSLLQYQ CDLKNSKGKI TVVQDTPEIL RVKENQKNFS SVLYKEDVSP GTAIGKTPEM MRVKQTQDHI SSVKYKEAIG QGTPIPDLPE VKRVKETQKH ISSVMYKENL GTGIPTTVTP EIERVKRNQE NFSSVLYKEN LGKGIPTPIT PEMERVKRNQ ENFSSVLYKE NMGKGTPLAV TPEMERVKHN QENISSVLYK ENVGKATATP VTPEMQRVKR NQENISSVLY KENLGKATPT PFTPEMERVK RNQENFSSVL YKENMRKATP TPVTPEMERA KRNQENISSV LYSDSFRKQI QGKAAYVLDT PEMRRVRETQ RHISTVKYHE DFEKHKGCFT PVVTDPITER VKKNMQDFSD INYRGIQRKV VEMEQKRNDQ DQETITGLRV WRTNPGSVFD YDPAEDNIQS RSLHMINVQA QRRSREQSRS ASALSISGGE EKSEHSEAPD HHLSTYSDGG VFAVSTAYKH AKTTELPQQR SSSVATQQTT VSSIPSHPST AGKIFRAMYD YMAADADEVS FKDGDAIINV QAIDEGWMYG TVQRTGRTGM LPANYVEAI //